Drug intelligence / Profile preview

Qizi Yusi Tang

Development stage: Preclinical
Administration: Oral

Overview

Qizi Yusi Tang (also known as Qizi Yusi Pill or Qiziyusi decoction) is a Traditional Chinese Medicine (TCM) formula that is being investigated for its potential to improve pregnancy outcomes in women of advanced reproductive age, particularly those undergoing in vitro fertilization (IVF). Research suggests that this compound preparation may enhance ovarian reserve capacity, ovarian response, and possibly promote endometrial receptivity. Its proposed mechanism of action involves the regulation of glycerophospholipid metabolism and steroid hormone biosynthesis. The formula is composed of several traditional Chinese herbs, and its efficacy is being evaluated in multicenter, randomized, double-blind, placebo-controlled clinical trials.

Other names: Qizi Yusi PillQiziyusi decoctionQZYSDQYP

Beyond the preview

Go deeper on Qizi Yusi Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qizi Yusi Tang.

Explore the full profile